Developer docs
API playgroundTry for free, no card

Search company profiles

Inbeeo

Full company profile

uuid000d372

Namestring
Inbeeo
Legal namestring
Inbeeo Limited
Websiteurl
inbeeo.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Inbeeo is a London-based management consulting firm providing strategic market access and pricing services to pharmaceutical and medical technology companies. Founded in 2018 by Hervé Lilliu and now part of the Enosium Life Science group, the firm operates a B2B professional services model with project-based consulting fees, delivering engagements that span the full product lifecycle from early clinical development through launch, pricing, reimbursement negotiation, and loss-of-exclusivity. Five service pillars—Define Value Strategy, Optimize Evidence Plan, Price Asset Right, Communicate Value, and Navigate Access Policies—are delivered alongside three proprietary products: i-vbp® (a cloud-based Multi-Criteria Decision Analysis application for quantitative value assessment), i-pec® (a curated network of more than 100 international payer, policy, clinician, and patient experts), and i-las® (an advisory forum convening global market access leaders).

The firm's revenue is generated through bespoke, non-publicly-priced consulting engagements for enterprise pharmaceutical and MedTech clients, with delivery supported by partner consultancies in geographies outside its core European, US, Canada, China, and Japan footprint. Customer evidence centres on engagements with Top-5 global pharmaceutical companies, large biotechs, specialty pharma, and MedTech suppliers across therapeutic areas including rare diseases, ATMPs, gene and cell therapies, oncology, CNS, and digital therapeutics. Credibility is reinforced by the UK Queen's Award for Enterprise in Innovation/R&D and a 2025 EcoVadis Silver sustainability rating, while the 2024 acquisition by Enosium Life Science integrates Inbeeo with Vyoo Agency (HEOR/Market Access) and Epione (Scientific Communication) into a multi-specialist life sciences services group operating from Inbeeo's headquarters at 14 Bedford Square, London.

Short descriptiontext

Inbeeo is a London-based pharma and MedTech consulting firm delivering strategic market access, pricing, and value-communication engagements, supported by three proprietary platforms—i-vbp®, i-pec®, and i-las®—and operating as part of Enosium Life Science.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
market access consulting, pharmaceutical pricing strategy, value-based pricing, health economics consulting, medtech market access
Industry2 codes
PRIMARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code2 codes
  • Management Consulting Services54161
  • Management, Scientific, and Technical Consulting Services5416
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Access Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Consulting Services
TypeProfessional Services
Description

B2B professional consulting engagements providing tailor-made solutions for market access and pricing challenges for pharmaceutical and MedTech companies. Engagements cover the full product lifecycle from early clinical development through launch and lifecycle management. Revenue is generated through project-based consulting fees.

inbeeo.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1i-vbp
Description

Cloud-based value-based pricing application that enables generation of custom value frameworks to demonstrate the full value of pharmaceutical and MedTech assets using MCDA methodology.

inbeeo.com
+2 more records
Core offering1 text field

Inbeeo delivers tailor-made strategy consulting to help pharmaceutical companies and medical technology suppliers realize the full value of their health technologies. The firm operates across the full product lifecycle—from early clinical development through launch and lifecycle management—providing value strategy, evidence planning, pricing, value communication, and access policy navigation. Services are powered by proprietary tools (i-vbp®, i-pec®, i-las®) and a global network of payer and clinical experts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • NICE cited Inbeeo's DELPHI survey report 17 times as key to reversing negative recommendation for biologic osteoporosis treatment in England
+1 more record
Product overview1 text field

Inbeeo is a strategic market access and pricing consulting firm for pharmaceutical and MedTech companies. The company offers three core proprietary products: i-vbp® (a cloud-based MCDA value assessment framework application), i-pec® (a payer and expert council network of 100+ international experts), and i-las® (a collaborative discussion platform for market access leaders). These tools are complemented by five consulting service areas: Define Your Value Strategy, Optimize Your Evidence Plan, Price Your Asset Right, Communicate the Value, and Navigate Access Policies. The integrated offering enables life sciences companies to create optimal value from innovative products across the entire product lifecycle from early development through launch and lifecycle management.

Product and service4 records
1Strategic Market Access & Pricing Consulting
CategoryManagement Consulting
Description

Tailor-made consulting engagements that help pharmaceutical companies and medical technology suppliers realize the full value of their health technologies, structured around five integrated service areas: Define Your Value Strategy, Optimize Your Evidence Plan, Price Your Asset Right, Communicate the Value, and Navigate Access Policies. Services span EU4, UK, US, Canada, China, Japan, and additional partner-supported geographies.

2i-vbp® (Interactive Value-Based Pricing)
CategoryProprietary Software / Analytics Tool
Description

Easy-to-use and secure cloud-based application that enables the generation of custom value frameworks tailored to demonstrate the full value of healthcare assets. Uses MCDA methodology to distil elements of value into an aggregated value summary to quantitatively compare assets on a value spectrum between 0 and 1, incorporating quality of evidence as a modifier and applying monetary value based on willingness-to-pay thresholds or price benchmarks.

3i-pec® (Payer and Expert Council)
CategoryExpert Network / Advisory Service
Description

A network of more than 100 international payers and experts with decades of experience in HTA, P&R and HEOR in their local markets. The network includes policy makers, payers, clinicians and patient experts who can be engaged to provide perspective on value, access, and pricing questions across multiple geographies.

4i-las® (Interactive Leaders Advisory Series)
CategoryCommunity / Advisory Platform
Description

A platform bringing together global market access leaders for collaborative discussions on industry-wide topics and challenges, designed to foster cross-industry dialogue on market access strategy.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Inbeeo is part of Enosium Life Science, an integrated life sciences services group. The acquisition positions Inbeeo as the strategic pricing and market access arm of the group, complementing Vyoo Agency (Strategic Health Economics and Market Access) and Epione (Scientific Communication). This integration offers clients access to a broader, connected range of capabilities across the healthcare product value chain.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Part of Enosium Life Science group, Vyoo Agency provides Strategic Health Economics and Market Access services, complementing Inbeeo's offerings within the integrated group.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Part of Enosium Life Science group, Epione provides Scientific Communication services, complementing Inbeeo's market access and pricing offerings within the integrated group.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Inbeeo partners with boutique consultancies and independent consultants globally to offer in-market expertise and specialist knowledge across various geographies beyond their core European, US, Canada, China, and Japan markets.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

World's largest life sciences services and consulting provider, offering technology, data, and advisory services including market access and HEOR. Represents the scaled incumbent against which Inbeeo competes on enterprise mandates.

TypeDirect peer
Description

US-based healthcare strategy and policy consultancy advising biopharma on market access, pricing, and value evidence. Direct peer with significant overlap in payer landscape and HTA advisory work.

3Trinity Partners
TypeDirect peer
Description

Life sciences strategy consultancy focused on commercial and market access strategy for global biopharma. Comparable on therapeutic-area depth and engagement-style with global pharma clients.

TypeDirect peer
Description

US-headquartered pharma strategy and market access consultancy serving global pharmaceutical and biotech clients on pricing, reimbursement, and value strategy. Closest direct peer to Inbeeo in therapeutic focus and boutique delivery model, though larger in scale.

5MAP BioPharma
TypeRegional player
Description

UK-based market access consultancy providing pricing, reimbursement, and HTA navigation services to pharma. Direct peer for European market access work, with similar geographic focus to Inbeeo's UK-EU base.

TypeEmerging player
Description

Specialized life sciences services provider including market access, HEOR, and commercialization support. Comparable on end-to-end access and commercialization support, but with a broader biomarker/Precision Medicine service mix.

TypeDirect peer
Description

Market access, health economics, and reimbursement consulting arm of Cencora (formerly AmerisourceBergen). Competes directly with Inbeeo on payer engagement, HEOR modeling, and value communications for pharma manufacturers.

TypeDirect peer
Description

Multi-HEOR and market access consultancy within the PPD clinical research business of Thermo Fisher Scientific. Directly comparable in HEOR, value evidence generation, and pricing support for global pharma clients.

9Lattice (formerly PRMA Consulting)
TypeDirect peer
Description

Specialist market access and HEOR consultancy supporting pharma clients globally on pricing, reimbursement, and value strategy. Closely comparable boutique peer with strong international delivery.

TypeDirect peer
Description

CRA's Life Sciences practice provides commercial, pricing, and market access strategy consulting to pharma and biotech. Closely comparable on strategy, pricing, and litigation-support work, but with the resources of a public advisory firm.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inbeeo

Pharmaceutical Market Access Consultinginbeeo.com

Inbeeo is a London-based pharma and MedTech consulting firm delivering strategic market access, pricing, and value-communication engagements, supported by three proprietary platforms—i-vbp®, i-pec®, and i-las®—and operating as part of Enosium Life Science.

What Inbeeo does

Inbeeo is a London-based management consulting firm providing strategic market access and pricing services to pharmaceutical and medical technology companies. Founded in 2018 by Hervé Lilliu and now part of the Enosium Life Science group, the firm operates a B2B professional services model with project-based consulting fees, delivering engagements that span the full product lifecycle from early clinical development through launch, pricing, reimbursement negotiation, and loss-of-exclusivity. Five service pillars—Define Value Strategy, Optimize Evidence Plan, Price Asset Right, Communicate Value, and Navigate Access Policies—are delivered alongside three proprietary products: i-vbp® (a cloud-based Multi-Criteria Decision Analysis application for quantitative value assessment), i-pec® (a curated network of more than 100 international payer, policy, clinician, and patient experts), and i-las® (an advisory forum convening global market access leaders).

The firm's revenue is generated through bespoke, non-publicly-priced consulting engagements for enterprise pharmaceutical and MedTech clients, with delivery supported by partner consultancies in geographies outside its core European, US, Canada, China, and Japan footprint. Customer evidence centres on engagements with Top-5 global pharmaceutical companies, large biotechs, specialty pharma, and MedTech suppliers across therapeutic areas including rare diseases, ATMPs, gene and cell therapies, oncology, CNS, and digital therapeutics. Credibility is reinforced by the UK Queen's Award for Enterprise in Innovation/R&D and a 2025 EcoVadis Silver sustainability rating, while the 2024 acquisition by Enosium Life Science integrates Inbeeo with Vyoo Agency (HEOR/Market Access) and Epione (Scientific Communication) into a multi-specialist life sciences services group operating from Inbeeo's headquarters at 14 Bedford Square, London.

Inbeeo firmographics

Firmographics
Name
Inbeeo
Legal name
Inbeeo Limited
Website
https://inbeeo.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Inbeeo is a London-based pharma and MedTech consulting firm delivering strategic market access, pricing, and value-communication engagements, supported by three proprietary platforms—i-vbp®, i-pec®, and i-las®—and operating as part of Enosium Life Science.
Ownership category
akta.pro rank

Inbeeo industry classification

Industry
Product category
Pharmaceutical Market Access Consulting
NAICS
Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Market access consulting
  • Pharmaceutical pricing strategy
  • Value-based pricing
  • Health economics consulting
  • Medtech market access

Where Inbeeo is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Inbeeo business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Strategic Consulting Services: B2B professional consulting engagements providing tailor-made solutions for market access and pricing challenges for pharmaceutical and MedTech companies. Engagements cover the full product lifecycle from early clinical development through launch and lifecycle management. Revenue is generated through project-based consulting fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Inbeeo product offering

Product offering

Core offering

Inbeeo delivers tailor-made strategy consulting to help pharmaceutical companies and medical technology suppliers realize the full value of their health technologies. The firm operates across the full product lifecycle—from early clinical development through launch and lifecycle management—providing value strategy, evidence planning, pricing, value communication, and access policy navigation. Services are powered by proprietary tools (i-vbp®, i-pec®, i-las®) and a global network of payer and clinical experts.

Product overview

Inbeeo is a strategic market access and pricing consulting firm for pharmaceutical and MedTech companies. The company offers three core proprietary products: i-vbp® (a cloud-based MCDA value assessment framework application), i-pec® (a payer and expert council network of 100+ international experts), and i-las® (a collaborative discussion platform for market access leaders). These tools are complemented by five consulting service areas: Define Your Value Strategy, Optimize Your Evidence Plan, Price Your Asset Right, Communicate the Value, and Navigate Access Policies. The integrated offering enables life sciences companies to create optimal value from innovative products across the entire product lifecycle from early development through launch and lifecycle management.

Differentiator

Problem solved

Functional benefit

Brands

  • i-vbp: Cloud-based value-based pricing application that enables generation of custom value frameworks to demonstrate the full value of pharmaceutical and MedTech assets using MCDA methodology.
  • i-pec
  • i-las

Products and services

  • Strategic Market Access & Pricing Consulting Tailor-made consulting engagements that help pharmaceutical companies and medical technology suppliers realize the full value of their health technologies, structured around five integrated service areas: Define Your Value Strategy, Optimize Your Evidence Plan, Price Your Asset Right, Communicate the Value, and Navigate Access Policies. Services span EU4, UK, US, Canada, China, Japan, and additional partner-supported geographies.
  • i-vbp® (Interactive Value-Based Pricing) Easy-to-use and secure cloud-based application that enables the generation of custom value frameworks tailored to demonstrate the full value of healthcare assets. Uses MCDA methodology to distil elements of value into an aggregated value summary to quantitatively compare assets on a value spectrum between 0 and 1, incorporating quality of evidence as a modifier and applying monetary value based on willingness-to-pay thresholds or price benchmarks.
  • i-pec® (Payer and Expert Council) A network of more than 100 international payers and experts with decades of experience in HTA, P&R and HEOR in their local markets. The network includes policy makers, payers, clinicians and patient experts who can be engaged to provide perspective on value, access, and pricing questions across multiple geographies.
  • i-las® (Interactive Leaders Advisory Series) A platform bringing together global market access leaders for collaborative discussions on industry-wide topics and challenges, designed to foster cross-industry dialogue on market access strategy.

Quantifiable outcome

  • NICE cited Inbeeo's DELPHI survey report 17 times as key to reversing negative recommendation for biologic osteoporosis treatment in England
  • +1 more outcomes

Companies that use Inbeeo

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles3 records

Inbeeo technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Inbeeo partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Enosium Life SciencecoreStrategic or Co-development PartnerInbeeo is part of Enosium Life Science, an integrated life sciences services group. The acquisition positions Inbeeo as the strategic pricing and market access arm of the group, complementing Vyoo Agency (Strategic Health Economics and Market Access) and Epione (Scientific Communication). This integration offers clients access to a broader, connected range of capabilities across the healthcare product value chain.
  • Vyoo AgencyminorStrategic or Co-development PartnerPart of Enosium Life Science group, Vyoo Agency provides Strategic Health Economics and Market Access services, complementing Inbeeo's offerings within the integrated group.
  • EpioneminorStrategic or Co-development PartnerPart of Enosium Life Science group, Epione provides Scientific Communication services, complementing Inbeeo's market access and pricing offerings within the integrated group.
  • Boutique Consultancies and Independent ConsultantsminorChannel Partner/ Reseller/ DistributorInbeeo partners with boutique consultancies and independent consultants globally to offer in-market expertise and specialist knowledge across various geographies beyond their core European, US, Canada, China, and Japan markets.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Inbeeo competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: World's largest life sciences services and consulting provider, offering technology, data, and advisory services including market access and HEOR. Represents the scaled incumbent against which Inbeeo competes on enterprise mandates.

Direct peers

  • Avalere Health: US-based healthcare strategy and policy consultancy advising biopharma on market access, pricing, and value evidence. Direct peer with significant overlap in payer landscape and HTA advisory work.
  • Trinity Partners: Life sciences strategy consultancy focused on commercial and market access strategy for global biopharma. Comparable on therapeutic-area depth and engagement-style with global pharma clients.
  • Putnam Associates: US-headquartered pharma strategy and market access consultancy serving global pharmaceutical and biotech clients on pricing, reimbursement, and value strategy. Closest direct peer to Inbeeo in therapeutic focus and boutique delivery model, though larger in scale.
  • Xcenda: Market access, health economics, and reimbursement consulting arm of Cencora (formerly AmerisourceBergen). Competes directly with Inbeeo on payer engagement, HEOR modeling, and value communications for pharma manufacturers.
  • Evidera: Multi-HEOR and market access consultancy within the PPD clinical research business of Thermo Fisher Scientific. Directly comparable in HEOR, value evidence generation, and pricing support for global pharma clients.
  • Lattice (formerly PRMA Consulting): Specialist market access and HEOR consultancy supporting pharma clients globally on pricing, reimbursement, and value strategy. Closely comparable boutique peer with strong international delivery.
  • Charles River Associates (CRA) – Life Sciences: CRA's Life Sciences practice provides commercial, pricing, and market access strategy consulting to pharma and biotech. Closely comparable on strategy, pricing, and litigation-support work, but with the resources of a public advisory firm.

Regional players

  • MAP BioPharma: UK-based market access consultancy providing pricing, reimbursement, and HTA navigation services to pharma. Direct peer for European market access work, with similar geographic focus to Inbeeo's UK-EU base.

Emerging players

  • Precision Medicine Group: Specialized life sciences services provider including market access, HEOR, and commercialization support. Comparable on end-to-end access and commercialization support, but with a broader biomarker/Precision Medicine service mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Inbeeo social profiles

Digital presence

Inbeeo compliance and trust

Trust signal

Compliance3 records

Inbeeo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inbeeo leadership team

Management profile

Number of profiles

Profiles6 records

Inbeeo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inbeeo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inbeeo

What does Inbeeo do?

Inbeeo delivers tailor-made strategy consulting to help pharmaceutical companies and medical technology suppliers realize the full value of their health technologies. The firm operates across the full product lifecycle—from early clinical development through launch and lifecycle management—providing value strategy, evidence planning, pricing, value communication, and access policy navigation. Services are powered by proprietary tools (i-vbp®, i-pec®, i-las®) and a global network of payer and clinical experts.

Is Inbeeo a public or private company?

Inbeeo is a private company. It is classified as corporate owned and is currently operating.

When was Inbeeo founded?

Inbeeo was founded in 2018. It employs 11 to 50 people.

Where is Inbeeo based?

Inbeeo is headquartered in London, United Kingdom, in the Europe region.

How does Inbeeo make money?

One revenue line is on record: strategic Consulting Services.

Who are Inbeeo's main competitors?

IQVIA is listed as a broad incumbent. Direct peers are Avalere Health, Trinity Partners, Putnam Associates, Xcenda, Evidera, Lattice (formerly PRMA Consulting) and Charles River Associates (CRA) – Life Sciences. MAP BioPharma is listed as a regional player. Precision Medicine Group is listed as an emerging player.

Does Inbeeo have an API?

No public API is recorded for Inbeeo.

What industry is Inbeeo in?

Inbeeo's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation, with a secondary code of HLAIALAH, Regulatory Strategy & IND/NDA/BLA Submissions Support. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales